Dr. med. Olaf Schmidt
Facharzt für Innere Medizin, Schwerpunkt Pneumologie
Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat® Inhaler in Patients with Chronic Obstructive Pulmonary Disease; R Aalbers, MR Maleki-Yazdi, A Hamilton, S Waitere-Wijker, Y Zhao, VC Amatto, O Schmidt, L Bjermer; Adv Ther. 2015 Sep;32(9):809-22. Adv Ther (2015) 32:809-822
Tiotropium + olodaterol shows clinically meaningful improvements in quality of life; D Singh, GT Ferguson, J Bolitschek, L Grönke, C Hallmann, N Bennett, R Abrahams, O Schmidt, L Bjermer; Respir Med. 2015 Oct;109(10):1312-9
Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials; HAM Kerstjens, TB Casale, ER Bleecker, EO Meltzer, E Pizzichini, O Schmidt, M Engel, LJ Bour, CB Verkleij, P Moroni-Zentgraf, ED Bateman; Lancet Respir Med. 2015;3(5):367-376
Anforderungen an die moderne Inhalationstherapie; O. Schmidt; Medizin Report aktuell Nr. 411166 in: PneumoNews 1/2015
Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO studies; D Singh, M Gaga, O Schmidt, L Bjermer, L Grönke, F Voß, GT Ferguson; Respiratory Research. 2016 Jun; 17:73
Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler e Results from a non-interventional study; O. Schmidt , W. Petro , G. Hoheisel , F. Kanniess , P. Oepen , B. Langer-Brauburger; Respiratory Medicine 131 (2017) 166e174
Tiotropium add-on therapy improves lung function in children with symptomatic moderate asthma; Christian Vogelberg, Michael Engel, István Laki, Jonathan A. Bernstein, Olaf Schmidt, Georges El Azzi, Petra Moroni-Zentgraf, Ralf Sigmund and Eckard Hamelmann; The Journal of Allergy an Clinical Immunology / In Practice / 2018
Spiroergometrie kompakt – Physiologie, Durchführung und Auswertung / Guidance to the Interpretation of Cardiopulmonary Exercise; T. Glaab, O. Schmidt, J. Fritsch; Georg Thieme Verlag KG Stuttgart · New York; Testing Pneumologie 2020; 74(02): 88-102 DOI: 10.1055/a-1069-0611
German Regional Variation of Acute and High Oral Corticosteroid Use for Asthma; Cassandra Nan, Olaf Schmidt, Robert Lindner, Yasemin Ilgin, Thomas Schultz, Lykke Hinsch Gylvin & Eugene R. Bleecker; Journal of Asthma; 01-2021; DOI: 10.1080/02770903.2021.1878532
Prevalence of Patients with Uncontrolled Asthma Despite NVL/GINA Step 4/5 Treatment in Germany; Karl-Christian Bergmann, Dirk Skowasch, Hartmut Timmermann, Robert Lindner, Johann Christian Virchow, Olaf Schmidt, Dirk Koschel, Claus Neurohr, Sebastian Heck, Katrin Milger; Journal of Asthma and Allergy; 2022:15; Dovepress
Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis; Roland Buhl, Thomas Wilke, Nils Picker, Olaf Schmidt, Marlene Hechtner, Anke Kondla, Ulf Maywald, Claus F Vogelmeier; International Journal of Chronic Obstructive Pulmonary Disease 2022:17 2355–2367; Dovepress
Treatment situation of patients with uncontrolled GINA 4 or 5 asthma in Germany; H Timmermann, K Milger, J C Virchow, O Schmidt, K C Bergmann, D Koschel, C Neurohr, F Scholz, R Lindner, S Heck, D Skowasch; European Respiratory Journal 2022 60: 244; DOI: 10.1183/13993003.congress-2022.244
Bronchodilator reversibility in the GAN severe asthma cohort; K Milger, D Skowasch, E Hamelmann, C Mümmler, M Idzko, M Gappa, M Jandl, C Körner-Rettberg, R Ehmann, O Schmidt, C Taube, A Holtdirk, H Timmermann, R Buhl, S Korn; Pubmed; PMID: 36000830; DOI: 10.18176/jiaci.0850
Fixed-dose combination fluticasone/formoterol for asthma treatment in a real-world setting: meta-analysis of exacerbation rates and asthma control; Alberto Papi, Murtaza Qasuri, Ernestine Chung, Mohamed Abdelbaset, Mohamed Aly Moussa, Vibeke Backer, Olaf Schmidt & Omar Usmani; European Clinical Respiratory Journal Feb 2023, 10:1, 2174642, DOI: 10.1080/20018525.2023.2174642
Dose-finding study for tiotropium and olodaterol when administered in combination via the Respimat® inhaler in patients with COPD; R Aalbers, RM Maleki-Yazdi, A Hamilton, S Waitere-Wijker, A Pivovarova, O Schmidt, L Bjermer;
European Respiratory Society (ERS) – International Congress 2012
Phase III trials to investigate tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: trial design and planned statistical analyses; TB Casale, ER Bleecker, E Meltzer, E Pizzichini, O Schmidt, ED Bateman, M Engel, LJ Bour, CB Verkleij, P Moroni-Zentgraf, HAM Kerstjens;
European Academy of Allergy and Clinical Immunology (EAACI) – International Congress 2013
Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: lung function and safety;
HAM Kerstjens, ER Bleecker, E Meltzer, TB Casale, E Pizzichini, O Schmidt, ED Bateman, M Engel, LJ Bour, CB Verkleij, P Moroni-Zentgraf;
European Respiratory Society (ERS) – International Congress 2013
Thoracic Society of Australia and New Zealand (TSANZ) – International Congress 2014
Congrès de pneumologie de langue française (CPLF) – International Congress 2014
Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e.V. (DGP) – Kongress der DGP 2014
Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate;
HAM Kerstjens, E Bleecker, E Meltzer, TB Casale, E Pizzichini, O Schmidt, M Engel, LJ Bour, CB Verkjeij, P Moroni-Zentgraf, ED Bateman;
European Respiratory Society (ERS) – International Congress 2013
Thoracic Society of Australia and New Zealand (TSANZ) – International Congress 2014
Congrès de pneumologie de langue française (CPLF) – International Congress 2014
Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e.V. (DGP) – Kongress der DGP 2014
Asthmabehandlung mit Fluticasonpropionat / Formoterol-Kombination: Zwischenergebnisse einer nicht-interventionellen Studie zur Sicherheit und Wirksamkeit; O Schmidt, F Kanniess, B Langer-Brauburger; Kongress der DGP 2015
FLT9501 ffairness – Studie; flutiform; eine neue Wirkstoffkombination zur Asthmabehandlung nicht- interventionelle Studie zur Sicherheit und Wirksamkeit Ergebnisse Interimsanalyse II; O Schmidt; Kongress der DGP 2015
Once-daily tiotropium Respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma; Schmidt O, Halpin D, Bateman E, Paggiaro P, Bleecker E, Engel M, Moroni-Zentgraf P, Schmidt H, Kerstjens H; Posterbeitrag Kongress der DGP 2015
Once-daily tiotropium Respimat add-on to ICS±LABA improves control across asthma severities; O Schmidt, M FitzGerald, H Kerstjens, P Paggiaro, K Ohta, M Ichinose, P Moroni-Zentgraf, M Engel, H Schmidt, ED Bateman; Posterbeitrag Kongress der DGP 2015
Once-daily tiotropium Respimat® is well tolerated and efficacious over 52 weeks in patients with symptomatic asthma in Japan receiving ICS ± LABAs: a randomized, double-blind, placebo-controlled study; O Schmidt, K Ohta, M Ichinose, Y Tohda, M Engel, P Moroni-Zentgraf, S Kunimitsu, W Sakamoto, M Adachi; Posterbeitrag Kongress der DGP 2015
Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo
D Singh, GT Ferguson, J Bolitschek, L Grönke, C Hallmann, N Bennett, R Abrahams, O Schmidt, L Bjermer;
European Respiratory Society (ERS) – International Congress 2015
Canadian Thoracic Society (CTS) – International Congress 2016
Tiotropium + olodaterol shows clinically meaningful improvements in quality of life versus placebo
D Singh, GT Ferguson, J Bolitschek, L Grönke, C Hallman, N Bennett, R Abrahams, O Schmidt, L Bjermer;
The International Primary Care Respiratory Group (IPCRG) – International Congress 2016
Fluticasone propionate/formoterol therapy for asthmatic patients: results of a non-interventional study
O. Schmidt, F. Kanniess, P. Oepen, B. Langer-Brauburger; European Respiratory Society (ERS) – International Congress 2016
Once-daily tiotropium Respimat add-on therapy improves lung function in children with moderate symptomatic asthma
Olaf Schmidt, Eckard Hamelmann, Christian Vogelberg, István Laki, Georges El Azzi, Michael Engel, Petra Moroni-Zentgraf, Helen Finnigan, Mark Vandewalker; European Respiratory Society (ERS) – International Congress 2016
Amélioration cliniquement pertinente de la qualité de vie avec l’association fixe tiotropium + olodaterol versus placebo chez les patients BPCO; P Berger, D Singh, GT Ferguson, J Bolitschek, L Grönke, R Abrahams, O Schmidt, L Bjermer;
Congrès de pneumologie de langue française (CPLF) – International Congress 2016
Safety and tolerability of once-daily tiotropium Respimat add-on therapy in children with moderate symptomatic asthma
Christian Vogelberg, István Laki, Olaf Schmidt, Eckard Hamelmann, Georges El Azzi, Michael Engel, Petra Moroni-Zentgraf, Helen Finnigan, Mark Vandewalker; European Respiratory Society (ERS) – International Congress 2016
Pooled analysis of the efficacy and safety from two non-interventional studies of fluticasone propionate/formoterol pMDI
Vibeke Backer, Olaf Schmidt, Birgit Langer-Brauburger, Tanja Schmidt, Carla Bennett, Dirk Lindner, Susanna Cuadripani, Birgit Grothe, Tim Overend; European Respiratory Society (ERS) – International Congress 2018
Therapie des schweren Asthmas – eine Frage der Präzision: Eine Orientierung aus Theorie und Praxis; Moderne Präzisionstherapie – die Perspektive aus der Praxis – Interaktive Falldiskussionen; O Schmidt, Koblenz; Präsentation Kongress der DGP 2019
Short-Term and Maintenance Oral Corticosteroid Use for German Patients with Asthma; Cassandra Nan, Robert Lindner, Yasemin Ilgin, Thomas Schultz, Olaf Schmidt, Lykke Hinsch Gylvin, Eugene R. Bleecker;
European Respiratory Society (ERS) – International Congress 2019;
Präsentation auf dem Kongress der DGP 2020 wurde pandemiebedingt abgesagt.
Rheinland-Pfalz atmet durch – Telemedizin für eine gesunde Lunge“ – Telemedizin wird von Asthmatikern angenommen und verbessert deren Lebensqualität; O. Schmidt, V. Hanrath;
Posterbeitrag Kongress der DGP 2020 (pandemiebedingt abgesagt)
Posterbeitrag Digitaler DGP Kongress, Juni 2021
Veröffentlichung in Pneumo News, Juni 2021
Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT); Marek Lommatzsch, Stephanie Korn, Olaf Schmidt, Hartmut Timmermann, Henrik Watz, Amr Radwan, Lucia de Prado-Gómez, Anne Atenhan, Sebastian Barbus, Mayank Thakur;
Posterbeitrag
European Respiratory Society (ERS) – International (Virtual Congress) 2021
European Academy of Allergy and Clinical Immunology (EACCI) – Hybrid Congress 2021
16. Deutscher Allergiekongress (DAK) – Dresden 2021
A comparison of clinical characteristics, initiated therapies, and outcomes in newly diagnosed COPD patients in in- and outpatient settings / Vergleich von klinischen Merkmalen, Behandlungsstrukturen und Therapieergebnissen bei Patienten mit stationären oder ambulanten COPD-Initialdiagnosen; Claus F. Vogelmeier, Nils Picker, Thomas Wilke, Marlene Hechtner, Angela Neitz, Ulf Maywald, Olaf Schmidt, Roland Buhl;
Posterbeitrag DGIM Kongress, Wiesbaden, Deutschland, Mai 2022
Prevalence of patients with uncontrolled asthma despite high intensity treatment (NVL/GINA step 4/5) in Germany; Bergmann K-C, Skowasch D, Timmermann H, Lindner R, Virchow J C, Schmidt O, Koschel D, Heck S, Milger K;
Posterbeitrag DGP, Leipzig, Deutschland, 25-28 Mai 2022
Erfahrungen mit Smartphone-basiertem Telemonitoring bei respiratorischen Erkrankungen während der SARS-CoV-2 Pandemie aus ärztlicher Sicht; Braun M, Schmidt O, Schultz T, Junker E, Hastenteufel T, Ackermann E, Defosse K, Schöbel C;
Posterbeitrag DGP, Leipzig, Deutschland, 25-28 Mai 2022;
Veröffentlichung in Der Internist 03/2022
Patienten-relevante Erfahrungen mit Smartphone-basiertem Telemonitoring bei respiratorischen Erkrankungen während der SARS-CoV-2 Pandemie; Braun M, Schmidt O, Schultz T, Woehrle H, Grosse Sundrup M, Schöbel C;
Posterbeitrag DGP, Leipzig, Deutschland, 25-28 Mai 2022;
Veröffentlichung in Der Internist 03/2022
Treatment situation of patients with uncontrolled GINA 4/5 asthma in Germany; Timmermann H., Milger K., Virchow J. Chr., Schmidt O., Bergmann K.-C., Koschel D., Neurohr C., Scholz F., Lindner R., Heck S., Skowasch D.; Posterbeitrag Internationaler Kongress der European Respiratory Society (ERS), Barcelona, Spanien 09-2022